TPI
TrumpEconomyImmigrationCrimeCongressHealthcareCourts
Subscribe
TPI
The Political Insider
thepoliticalinsider.com|Privacy Policy|Contact|© 2026 The Publisher Desk

White House Speeds FDA Psychedelic Drug Reviews

April 20, 2026·19 days ago·via Pharmaceutical Commerce
White House Speeds FDA Psychedelic Drug Reviews
The White House directs the FDA to accelerate reviews for psychedelic treatments targeting mental health issues, aiming to fast-track approvals for therapies like psilocybin and MDMA. This move promises quicker access to innovative options for veterans battling PTSD and everyday Americans crushed by depression - a win for individual liberty over suffocating bureaucracy. Read more about this...

Related Coverage

WebsiteYale invites Hasan Piker to trash America and accidentally exposes the left’s 2026 playbook — The Blaze
WebsiteTriggered 'Journalists' Plan to Give Trump a 1st Amendment Lecture at the WHCD (Per This Whiny Petition) — Twitchy
SubstackThese Trump Voters Are Turning on Him Over Iran and Gas Prices — The Bulwark
WebsiteOver 250 journalists demand reporters ‘forcefully’ protest Trump at White House Correspondents’ Dinner — New York Post
WebsiteThe Look on Ro Khanna's Face While Being Reminded How Obama Coddled Iran (and Hezbollah) Said it ALL — Twitchy
WebsiteThe White House Meets to Discuss Midterm Battle Plan — The Daily Signal
WebsiteOver 250 Journalists Sign Letter Demanding ‘Forceful’ Protest Against Trump at White House Correspondents’ Dinner — The Gateway Pundit